BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17336214)

  • 1. Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
    Chang DT; Feigenberg SJ; Indelicato DJ; Morris CG; Lightsey J; Grobmyer SR; Copeland EM; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1043-51. PubMed ID: 17336214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy.
    Macdonald SM; Abi-Raad RF; Alm El-Din MA; Niemierko A; Kobayashi W; McGrath JJ; Goldberg SI; Powell S; Smith B; Taghian AG
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1297-303. PubMed ID: 19327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmastectomy radiotherapy of the chest wall. Comparison of electron-rotation technique and common tangential photon fields.
    Hehr T; Classen J; Huth M; Durst I; Christ G; Bamberg M; Budach W
    Strahlenther Onkol; 2004 Oct; 180(10):629-36. PubMed ID: 15480511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postmastectomy radiotherapy for early breast cancer].
    Wang S; Li Y; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):68-70. PubMed ID: 11977644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome.
    Geara FB; Nasr E; Tucker SL; Charafeddine M; Dabaja B; Eid T; Abbas J; Salem Z; Shamseddine A; Issa P; El Saghir N
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):364-9. PubMed ID: 17324529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (Ionta MT; Atzori F; Deidda MC; Pusceddu V; Palmeri S; Frau B; Murgia M; Barca M; Minerba L; Massidda B
    Oncologist; 2009 Nov; 14(11):1051-60. PubMed ID: 19897535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
    Stranzl H; Mayer R; Ofner P; Peintinger F; Prettenhofer U; Hackl A
    Strahlenther Onkol; 2004 Jan; 180(1):31-7. PubMed ID: 14704842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
    Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
    Reddy SG; Kiel KD
    Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
    Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
    Stranzl H; Peintinger F; Ofner P; Prettenhofer U; Mayer R; Hackl A
    Strahlenther Onkol; 2004 Oct; 180(10):623-8. PubMed ID: 15480510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal ratios in node-positive breast cancer--long-term study to clarify discrepancy of role of supraclavicular and axillary regional radiotherapy.
    Tai P; Joseph K; Sadikov E; Mahmood S; Lien F; Yu E
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):662-6. PubMed ID: 17449196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation.
    Fortin A; Dagnault A; Blondeau L; Vu TT; Larochelle M
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):33-9. PubMed ID: 16542789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.
    Sautter-Bihl ML; Souchon R; Budach W; Sedlmayer F; Feyer P; Harms W; Haase W; Dunst J; Wenz F; Sauer R
    Strahlenther Onkol; 2008 Jul; 184(7):347-53. PubMed ID: 19016032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
    Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
    J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.